Tudriqev FDA Approval – Tudriqev has been granted accelerated approval by the U.S. Food and Drug Administration for certain patients with advanced cutaneous melanoma. The decision could give patients with disease that has spread, cannot be removed surgically or has continued to progress after earlier therapy a new treatment option. If true, the reported FDA…

Continue Reading